Search Results 191-200 of 16287 for nivolumab
... nivolumab. In both patients, there was development of myositis with rhabdomyolysis, early progressive and refractory cardiac electrical instability, and ...
The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...
... Nivolumab in Patients with Previously Treated Advanced Differentiated Thyroid Cancer". J Clin Endocrinol Metab 2025 Jun 17; 110 (7):e2425-e2426. View PubMed ...
The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with nivolumab in adult subjects with advanced and/or ...
The purpose of this study is to determine whether Nivolumab, in combination with brentuximab vedotin, is safe and effective in patients with certain subtypes of ...
The purpose of this study is to test the effectiveness and tolerability of the combination of Nivolumab and Ipilimumab compared to Pemetrexed and Cisplatin ...
... Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. J Blood Med. 2024; 15:29-34 Epub 2024 Jan 24. View PubMed; Kettani ME, Shah K, Farooq H, Li ...
Ansell led the clinical trial that resulted in the approval by the U.S. Food and Drug Administration (FDA) of nivolumab (Opdivo) for Hodgkin's lymphoma.
Abatacept has recently looked promising for the treatment of patients with complex CVID. In-home Versus In-Clinic Subcutaneous Nivolumab Administration through ...
... nivolumab for mesothelioma. Dr. Mansfield explores translational projects to discover and validate biomarkers in thoracic malignancies. He has received ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.